1. Medtech Insight
  2. >>Geography
  3. >>Europe

How The EU Must Address Regulatory Hurdles Deterring Medtech Investors

The EU Should Assess Certain Successful US Regulatory Strategies

 
• By Amanda Maxwell

In the EU, developers struggle to tell potential investors how many trials a device might require, the potential duration or associated costs. Tom Melvin explains how to tackle these issues in a third piece* based on a recent interview.

Innovative idea solution concept and new thinking business symbol as a light bulb breaking through a maze or labyrinth as an icon for innovation and invention. - Illustration
EU Needs To Break Through Its Medtech Innovation Barriers

The EU must amend its regulations to make it easier for developers and start-ups to attract investment in the EU and to “thoroughly demonstrate that safe innovation can progress through the system.”

If these issues, are not tackled, “then EU competitiveness remains at stake,” regulatory expert Tom Melvin told

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography